Reprogrammed: A biotechnology Podcast
Dude, where's my CAR construct?
· 14 min · Temporada 1 Episódio 9
Notas do episódio
Over the past episodes of Reprogrammed, we’ve followed the rapid evolution of CAR T cell therapy—from early experiments demonstrating that antibody-based chimeric receptors could trigger T cell activation and IL-2 production, to the incorporation of co-stimulatory domains like CD28 and 4-1BB that dramatically improved T cell survival and cytotoxic efficacy.
In episode 5, we saw how CD28 co-stimulation, when engineered into CARs, could prevent Activation-Induced Cell Death (AICD) and promote proliferation. Then, in episode 6, we contrasted this with 4-1BB-based signaling, which provided a…
Site: podcasters.spotify.com
